Citadel Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $310K | Sell |
3,200
-4,400
| -58% | -$451K | ﹤0.01% | 10400 |
|
|
2025
Q4 | $807K | Sell |
7,600
-10,500
| -58% | -$1.22M | ﹤0.01% | 7900 |
|
|
2025
Q3 | $2.3M | Buy |
18,100
+7,200
| +66% | +$857K | ﹤0.01% | 5792 |
|
|
2025
Q2 | $1.34M | Sell |
10,900
-9,200
| -46% | -$1.05M | ﹤0.01% | 6482 |
|
|
2025
Q1 | $2.04M | Buy |
20,100
+6,000
| +43% | +$586K | ﹤0.01% | 5499 |
|
|
2024
Q4 | $1.3M | Sell |
14,100
-10,100
| -42% | -$992K | ﹤0.01% | 6503 |
|
|
2024
Q3 | $2.34M | Sell |
24,200
-5,900
| -20% | -$530K | ﹤0.01% | 5237 |
|
|
2024
Q2 | $2.58M | Sell |
30,100
-25,800
| -46% | -$2.17M | ﹤0.01% | 4840 |
|
|
2024
Q1 | $4.62M | Buy |
55,900
+37,700
| +207% | +$2.76M | ﹤0.01% | 4068 |
|
|
2023
Q4 | $1.21M | Sell |
18,200
-5,200
| -22% | -$337K | ﹤0.01% | 6298 |
|
|
2023
Q3 | $1.57M | Buy |
23,400
+4,900
| +26% | +$337K | ﹤0.01% | 5662 |
|
|
2023
Q2 | $1.25M | Buy |
18,500
+9,800
| +113% | +$614K | ﹤0.01% | 5995 |
|
|
2023
Q1 | $471K | Sell |
8,700
-3,800
| -30% | -$221K | ﹤0.01% | 8443 |
|
|
2022
Q4 | $748K | Sell |
12,500
-40,000
| -76% | -$2.18M | ﹤0.01% | 7402 |
|
|
2022
Q3 | $2.38M | Buy |
52,500
+29,748
| +131% | +$1.49M | ﹤0.01% | 5263 |
|
|
2022
Q2 | $1.01M | Buy |
22,752
+13,073
| +135% | +$671K | ﹤0.01% | 6985 |
|
|
2022
Q1 | $548K | Sell |
9,679
-81,579
| -89% | -$4.26M | ﹤0.01% | 9162 |
|
|
2021
Q4 | $4.74M | Sell |
91,258
-252
| -0.3% | -$13K | ﹤0.01% | 4384 |
|
|
2021
Q3 | $5.46M | Sell |
91,510
-13,324
| -13% | -$838K | ﹤0.01% | 4142 |
|
|
2021
Q2 | $6.51M | Buy |
104,834
+69,638
| +198% | +$4.64M | ﹤0.01% | 3889 |
|
|
2021
Q1 | $2.29M | Buy |
35,196
+9,427
| +37% | +$615K | ﹤0.01% | 6068 |
|
|
2020
Q4 | $1.7M | Sell |
25,769
-8,296
| -24% | -$488K | ﹤0.01% | 5717 |
|
|
2020
Q3 | $1.76M | Buy |
34,065
+6,160
| +22% | +$316K | ﹤0.01% | 4958 |
|
|
2020
Q2 | $1.38M | Sell |
27,905
-38,465
| -58% | -$2.08M | ﹤0.01% | 5239 |
|
|
2020
Q1 | $3.38M | Buy |
66,370
+50,909
| +329% | +$2.94M | ﹤0.01% | 3276 |
|
|
2019
Q4 | $852K | Sell |
15,461
-10,182
| -40% | -$553K | ﹤0.01% | 5890 |
|
|
2019
Q3 | $1.29M | Sell |
25,643
-8,045
| -24% | -$404K | ﹤0.01% | 5160 |
|
|
2019
Q2 | $1.7M | Buy |
33,688
+12,947
| +62% | +$628K | ﹤0.01% | 4798 |
|
|
2019
Q1 | $964K | Buy |
20,741
+1,760
| +9% | +$89.2K | ﹤0.01% | 5654 |
|
|
2018
Q4 | $932K | Sell |
18,981
-14,078
| -43% | -$801K | ﹤0.01% | 5423 |
|
|
2018
Q3 | $2.05M | Buy |
33,059
+19,735
| +148% | +$1.2M | ﹤0.01% | 4373 |
|
|
2018
Q2 | $718K | Sell |
13,324
-629
| -5% | -$31.4K | ﹤0.01% | 5787 |
|
|
2018
Q1 | $635K | Buy |
13,953
+2,766
| +25% | +$119K | ﹤0.01% | 5489 |
|
|
2017
Q4 | $440K | Buy |
11,187
+502
| +5% | +$19.1K | ﹤0.01% | 5849 |
|
|
2017
Q3 | $394K | Sell |
10,685
-628
| -6% | -$22.4K | ﹤0.01% | 5653 |
|
|
2017
Q2 | $436K | Buy |
11,313
+3,394
| +43% | +$124K | ﹤0.01% | 5305 |
|
|
2017
Q1 | $270K | Buy |
+7,919
| New | +$260K | ﹤0.01% | 6031 |
|
|
2016
Q4 | – | Sell |
-17,095
| Closed | -$552K | – | 7364 |
|
|
2016
Q3 | $552K | Buy |
17,095
+6,285
| +58% | +$204K | ﹤0.01% | 4708 |
|
|
2016
Q2 | $334K | Sell |
10,810
-6,034
| -36% | -$189K | ﹤0.01% | 5058 |
|
|
2016
Q1 | $504K | Buy |
16,844
+3,143
| +23% | +$86.8K | ﹤0.01% | 4394 |
|
|
2015
Q4 | $379K | Sell |
13,701
-10,308
| -43% | -$293K | ﹤0.01% | 4861 |
|
|
2015
Q3 | $733K | Buy |
24,009
+14,079
| +142% | +$490K | ﹤0.01% | 4240 |
|
|
2015
Q2 | $364K | Sell |
9,930
-4,903
| -33% | -$175K | ﹤0.01% | 5456 |
|
|
2015
Q1 | $523K | Buy |
14,833
+1,257
| +9% | +$43K | ﹤0.01% | 4839 |
|
|
2014
Q4 | $415K | Buy |
13,576
+12,445
| +1,100% | +$388K | ﹤0.01% | 4974 |
|
|
2014
Q3 | $33K | Buy |
+1,131
| New | +$34.5K | ﹤0.01% | 7152 |
|
|
2014
Q2 | – | Sell |
-8,171
| Closed | -$234K | – | 8025 |
|
|
2014
Q1 | $234K | Buy |
8,171
+4,903
| +150% | +$128K | ﹤0.01% | 5342 |
|
|
2013
Q4 | $87K | Buy |
+3,268
| New | +$90.9K | ﹤0.01% | 5717 |
|
|
2013
Q3 | – | Sell |
-13,827
| Closed | -$317K | – | 6761 |
|
|
2013
Q2 | $317K | Buy |
+13,827
| New | +$312K | ﹤0.01% | 4249 |
|
Other funds holding EHC
VPM
VCM
Citadel Advisors's EHC Position: Q1 2026 in Review
Citadel Advisors increased its Encompass Health (EHC) stake by 336% in Q1 2026, buying an estimated $40.4M and bringing the position to 511,887 shares worth $49.5M. The position accounts for 0.01% of the portfolio, ranked #1369.
Citadel Advisors first reported a position in EHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $132M in Q2 2024. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Citadel Advisors held 511,887 shares of Encompass Health worth $49.5M as of Q1 2026.
- Citadel Advisors bought 394,416 Encompass Health shares in Q1 2026, an estimated $40.4M.
- Encompass Health made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1369 holding.
- Citadel Advisors first reported a position in Encompass Health in Q2 2013 and has held it in 50 quarters since.
- Citadel Advisors's Encompass Health position peaked at $132M in Q2 2024.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.